You are here

Article Text

Article menu
Download PDFPDF
PostScript
Correspondence
Authors' response
  1. Monica Facco1,2,
  2. Gianpietro Semenzato1,2,
  3. Carlo Agostini1,2
  1. 1Department of Clinical and Experimental Medicine, Hematology-Immunology Section, Padua University School of Medicine, Padova, Italy
  2. 2Venetian Institute of Molecular Medicine, Padua University School of Medicine, Padova, Italy
  1. Correspondence to Carlo Agostini, Department of Clinical and Experimental Medicine, Padua University School of Medicine, Padova, Italy; carlo.agostini{at}unipd.it

https://doi.org/10.1136/thoraxjnl-2011-200387

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We would like to thank Dr Parisinos for his letter and interest in our study on the role of Th17 cells in sarcoidosis.1 His recent report on the development of sarcoidosis in two patients affected by Crohn's disease and treated with natalizumab2 further highlights the indubitable link existing between the immune pathogenesis of the two disorders. In fact, sarcoidosis and Crohn's disease are both characterised by …

    View Full Text

    Footnotes

    • Linked article 200290

    • Competing interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles